Loading…

Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation

Studies were performed to elucidate the mechanism responsible for the reduction in K m values of UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates observed for incubations conducted in the presence of albumin. Addition of bovine serum albumin (BSA) and fatty acid-free human serum albumin (HSA-FAF)...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pharmacology and experimental therapeutics 2007-04, Vol.321 (1), p.137-147
Main Authors: Rowland, Andrew, Gaganis, Paraskevi, Elliot, David J, Mackenzie, Peter I, Knights, Kathleen M, Miners, John O
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c392t-190b3446cb004d95134209b4f8de7f7ad288b4674d0d39403444c8cda2eec15d3
cites cdi_FETCH-LOGICAL-c392t-190b3446cb004d95134209b4f8de7f7ad288b4674d0d39403444c8cda2eec15d3
container_end_page 147
container_issue 1
container_start_page 137
container_title The Journal of pharmacology and experimental therapeutics
container_volume 321
creator Rowland, Andrew
Gaganis, Paraskevi
Elliot, David J
Mackenzie, Peter I
Knights, Kathleen M
Miners, John O
description Studies were performed to elucidate the mechanism responsible for the reduction in K m values of UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates observed for incubations conducted in the presence of albumin. Addition of bovine serum albumin (BSA) and fatty acid-free human serum albumin (HSA-FAF), but not “crude” HSA, resulted in an approximate 90% reduction in the K m values for the glucuronidation of zidovudine (AZT) by human liver microsomes (HLM) and UGT2B7 and a 50 to 75% reduction in the S 50 for 4-methylumbelliferone (4MU) glucuronidation by UGT2B7, without affecting V max . Oleic, linoleic, and arachidonic acids were shown to be the most abundant unsaturated long-chain fatty acids present in crude HSA and in the membranes of HLM and human embryonic kidney (HEK)293 cells, and it was demonstrated that these and other unsaturated long-chain fatty acids were UGT2B7 substrates. Glucuronides with R f (retention factor) values corresponding to the glucuronides of linoleic and arachidonic acid were detected when HLM and HEK293 cell lysates were incubated with radiolabeled cofactor, and the intensity of the bands was modulated by the presence of crude HSA (increased) and BSA or HSA-FAF (decreased). Oleic, linoleic, and arachidonic acid inhibited AZT and 4MU glucuronidation by HLM and/or UGT2B7, due to an increase in K m /S 50 without a change in V max . Addition of BSA and HSA-FAF reversed the inhibition. Likewise, coexpression of UGT2B7 and HSA in HEK293 cells reduced the K m /S 50 values of these substrates. It is postulated that BSA and HSA-FAF sequester inhibitory fatty acids released during incubations, and the apparent high K m values observed for UGT2B7 substrates arise from the presence of these endogenous inhibitors.
doi_str_mv 10.1124/jpet.106.118216
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70293028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70293028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-190b3446cb004d95134209b4f8de7f7ad288b4674d0d39403444c8cda2eec15d3</originalsourceid><addsrcrecordid>eNpFkUlrHDEQRoVJsCeOz7kFnXJrW1tvuXkZOwOGhBD7KtSSelpGLXUktZP-T_mR0SxgdCgVvHpF8QHwCaNLjAm7epl0usSoyl1DcHUCVrgkuEAY0XdghRAhBS2r8gx8iPEFIcxYRU_BGa4JrUnZrMC_G-OUcVvoe7hxg-lM8mGB9yKlBV5LoyLcRPhTx8m7aDqrYe8DTIOGazcIJ_WoXdoNP939KB7sLOfgnY-LTUG42Osgoobkps6uZF5NlnbZa7t5NO4r3IyTNVIkk-V7sXHw2aTgi_3n1cP13yyavN0zH8H7XtioL471HDzdr3_dfisevz9sbq8fC0lbkgrcoo7mS2WHEFNtiSkjqO1Y3yhd97VQpGk6VtVMIUVbhjLLZCOVIFpLXCp6Dr4cvFPwv2cdEx9NlNpa4bSfI68RaSkiTQavDqAMPsagez4FM4qwcIz4LiC-Cyg3FT8ElCc-H9VzN2r1xh8Teds9mO3wxwTNp0GEUUhv_XbhlGCeH63pf_IenDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70293028</pqid></control><display><type>article</type><title>Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation</title><source>Freely Accessible Journals</source><creator>Rowland, Andrew ; Gaganis, Paraskevi ; Elliot, David J ; Mackenzie, Peter I ; Knights, Kathleen M ; Miners, John O</creator><creatorcontrib>Rowland, Andrew ; Gaganis, Paraskevi ; Elliot, David J ; Mackenzie, Peter I ; Knights, Kathleen M ; Miners, John O</creatorcontrib><description>Studies were performed to elucidate the mechanism responsible for the reduction in K m values of UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates observed for incubations conducted in the presence of albumin. Addition of bovine serum albumin (BSA) and fatty acid-free human serum albumin (HSA-FAF), but not “crude” HSA, resulted in an approximate 90% reduction in the K m values for the glucuronidation of zidovudine (AZT) by human liver microsomes (HLM) and UGT2B7 and a 50 to 75% reduction in the S 50 for 4-methylumbelliferone (4MU) glucuronidation by UGT2B7, without affecting V max . Oleic, linoleic, and arachidonic acids were shown to be the most abundant unsaturated long-chain fatty acids present in crude HSA and in the membranes of HLM and human embryonic kidney (HEK)293 cells, and it was demonstrated that these and other unsaturated long-chain fatty acids were UGT2B7 substrates. Glucuronides with R f (retention factor) values corresponding to the glucuronides of linoleic and arachidonic acid were detected when HLM and HEK293 cell lysates were incubated with radiolabeled cofactor, and the intensity of the bands was modulated by the presence of crude HSA (increased) and BSA or HSA-FAF (decreased). Oleic, linoleic, and arachidonic acid inhibited AZT and 4MU glucuronidation by HLM and/or UGT2B7, due to an increase in K m /S 50 without a change in V max . Addition of BSA and HSA-FAF reversed the inhibition. Likewise, coexpression of UGT2B7 and HSA in HEK293 cells reduced the K m /S 50 values of these substrates. It is postulated that BSA and HSA-FAF sequester inhibitory fatty acids released during incubations, and the apparent high K m values observed for UGT2B7 substrates arise from the presence of these endogenous inhibitors.</description><identifier>ISSN: 0022-3565</identifier><identifier>EISSN: 1521-0103</identifier><identifier>DOI: 10.1124/jpet.106.118216</identifier><identifier>PMID: 17237258</identifier><language>eng</language><publisher>United States: American Society for Pharmacology and Experimental Therapeutics</publisher><subject>Albumins - pharmacology ; Animals ; Anti-HIV Agents - metabolism ; Blotting, Western ; Cattle ; Chromatography, High Pressure Liquid ; Data Interpretation, Statistical ; Fatty Acids - metabolism ; Glucuronides - metabolism ; Glucuronosyltransferase - metabolism ; Humans ; Hymecromone - analogs &amp; derivatives ; Hymecromone - metabolism ; In Vitro Techniques ; Kinetics ; Microsomes - metabolism ; Protein Binding ; Recombinant Proteins - metabolism ; Serum Albumin - pharmacology ; Serum Albumin, Bovine - pharmacology ; Zidovudine - metabolism</subject><ispartof>The Journal of pharmacology and experimental therapeutics, 2007-04, Vol.321 (1), p.137-147</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-190b3446cb004d95134209b4f8de7f7ad288b4674d0d39403444c8cda2eec15d3</citedby><cites>FETCH-LOGICAL-c392t-190b3446cb004d95134209b4f8de7f7ad288b4674d0d39403444c8cda2eec15d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17237258$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rowland, Andrew</creatorcontrib><creatorcontrib>Gaganis, Paraskevi</creatorcontrib><creatorcontrib>Elliot, David J</creatorcontrib><creatorcontrib>Mackenzie, Peter I</creatorcontrib><creatorcontrib>Knights, Kathleen M</creatorcontrib><creatorcontrib>Miners, John O</creatorcontrib><title>Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation</title><title>The Journal of pharmacology and experimental therapeutics</title><addtitle>J Pharmacol Exp Ther</addtitle><description>Studies were performed to elucidate the mechanism responsible for the reduction in K m values of UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates observed for incubations conducted in the presence of albumin. Addition of bovine serum albumin (BSA) and fatty acid-free human serum albumin (HSA-FAF), but not “crude” HSA, resulted in an approximate 90% reduction in the K m values for the glucuronidation of zidovudine (AZT) by human liver microsomes (HLM) and UGT2B7 and a 50 to 75% reduction in the S 50 for 4-methylumbelliferone (4MU) glucuronidation by UGT2B7, without affecting V max . Oleic, linoleic, and arachidonic acids were shown to be the most abundant unsaturated long-chain fatty acids present in crude HSA and in the membranes of HLM and human embryonic kidney (HEK)293 cells, and it was demonstrated that these and other unsaturated long-chain fatty acids were UGT2B7 substrates. Glucuronides with R f (retention factor) values corresponding to the glucuronides of linoleic and arachidonic acid were detected when HLM and HEK293 cell lysates were incubated with radiolabeled cofactor, and the intensity of the bands was modulated by the presence of crude HSA (increased) and BSA or HSA-FAF (decreased). Oleic, linoleic, and arachidonic acid inhibited AZT and 4MU glucuronidation by HLM and/or UGT2B7, due to an increase in K m /S 50 without a change in V max . Addition of BSA and HSA-FAF reversed the inhibition. Likewise, coexpression of UGT2B7 and HSA in HEK293 cells reduced the K m /S 50 values of these substrates. It is postulated that BSA and HSA-FAF sequester inhibitory fatty acids released during incubations, and the apparent high K m values observed for UGT2B7 substrates arise from the presence of these endogenous inhibitors.</description><subject>Albumins - pharmacology</subject><subject>Animals</subject><subject>Anti-HIV Agents - metabolism</subject><subject>Blotting, Western</subject><subject>Cattle</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Data Interpretation, Statistical</subject><subject>Fatty Acids - metabolism</subject><subject>Glucuronides - metabolism</subject><subject>Glucuronosyltransferase - metabolism</subject><subject>Humans</subject><subject>Hymecromone - analogs &amp; derivatives</subject><subject>Hymecromone - metabolism</subject><subject>In Vitro Techniques</subject><subject>Kinetics</subject><subject>Microsomes - metabolism</subject><subject>Protein Binding</subject><subject>Recombinant Proteins - metabolism</subject><subject>Serum Albumin - pharmacology</subject><subject>Serum Albumin, Bovine - pharmacology</subject><subject>Zidovudine - metabolism</subject><issn>0022-3565</issn><issn>1521-0103</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNpFkUlrHDEQRoVJsCeOz7kFnXJrW1tvuXkZOwOGhBD7KtSSelpGLXUktZP-T_mR0SxgdCgVvHpF8QHwCaNLjAm7epl0usSoyl1DcHUCVrgkuEAY0XdghRAhBS2r8gx8iPEFIcxYRU_BGa4JrUnZrMC_G-OUcVvoe7hxg-lM8mGB9yKlBV5LoyLcRPhTx8m7aDqrYe8DTIOGazcIJ_WoXdoNP939KB7sLOfgnY-LTUG42Osgoobkps6uZF5NlnbZa7t5NO4r3IyTNVIkk-V7sXHw2aTgi_3n1cP13yyavN0zH8H7XtioL471HDzdr3_dfisevz9sbq8fC0lbkgrcoo7mS2WHEFNtiSkjqO1Y3yhd97VQpGk6VtVMIUVbhjLLZCOVIFpLXCp6Dr4cvFPwv2cdEx9NlNpa4bSfI68RaSkiTQavDqAMPsagez4FM4qwcIz4LiC-Cyg3FT8ElCc-H9VzN2r1xh8Teds9mO3wxwTNp0GEUUhv_XbhlGCeH63pf_IenDw</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Rowland, Andrew</creator><creator>Gaganis, Paraskevi</creator><creator>Elliot, David J</creator><creator>Mackenzie, Peter I</creator><creator>Knights, Kathleen M</creator><creator>Miners, John O</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070401</creationdate><title>Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation</title><author>Rowland, Andrew ; Gaganis, Paraskevi ; Elliot, David J ; Mackenzie, Peter I ; Knights, Kathleen M ; Miners, John O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-190b3446cb004d95134209b4f8de7f7ad288b4674d0d39403444c8cda2eec15d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Albumins - pharmacology</topic><topic>Animals</topic><topic>Anti-HIV Agents - metabolism</topic><topic>Blotting, Western</topic><topic>Cattle</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Data Interpretation, Statistical</topic><topic>Fatty Acids - metabolism</topic><topic>Glucuronides - metabolism</topic><topic>Glucuronosyltransferase - metabolism</topic><topic>Humans</topic><topic>Hymecromone - analogs &amp; derivatives</topic><topic>Hymecromone - metabolism</topic><topic>In Vitro Techniques</topic><topic>Kinetics</topic><topic>Microsomes - metabolism</topic><topic>Protein Binding</topic><topic>Recombinant Proteins - metabolism</topic><topic>Serum Albumin - pharmacology</topic><topic>Serum Albumin, Bovine - pharmacology</topic><topic>Zidovudine - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rowland, Andrew</creatorcontrib><creatorcontrib>Gaganis, Paraskevi</creatorcontrib><creatorcontrib>Elliot, David J</creatorcontrib><creatorcontrib>Mackenzie, Peter I</creatorcontrib><creatorcontrib>Knights, Kathleen M</creatorcontrib><creatorcontrib>Miners, John O</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rowland, Andrew</au><au>Gaganis, Paraskevi</au><au>Elliot, David J</au><au>Mackenzie, Peter I</au><au>Knights, Kathleen M</au><au>Miners, John O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation</atitle><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle><addtitle>J Pharmacol Exp Ther</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>321</volume><issue>1</issue><spage>137</spage><epage>147</epage><pages>137-147</pages><issn>0022-3565</issn><eissn>1521-0103</eissn><abstract>Studies were performed to elucidate the mechanism responsible for the reduction in K m values of UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates observed for incubations conducted in the presence of albumin. Addition of bovine serum albumin (BSA) and fatty acid-free human serum albumin (HSA-FAF), but not “crude” HSA, resulted in an approximate 90% reduction in the K m values for the glucuronidation of zidovudine (AZT) by human liver microsomes (HLM) and UGT2B7 and a 50 to 75% reduction in the S 50 for 4-methylumbelliferone (4MU) glucuronidation by UGT2B7, without affecting V max . Oleic, linoleic, and arachidonic acids were shown to be the most abundant unsaturated long-chain fatty acids present in crude HSA and in the membranes of HLM and human embryonic kidney (HEK)293 cells, and it was demonstrated that these and other unsaturated long-chain fatty acids were UGT2B7 substrates. Glucuronides with R f (retention factor) values corresponding to the glucuronides of linoleic and arachidonic acid were detected when HLM and HEK293 cell lysates were incubated with radiolabeled cofactor, and the intensity of the bands was modulated by the presence of crude HSA (increased) and BSA or HSA-FAF (decreased). Oleic, linoleic, and arachidonic acid inhibited AZT and 4MU glucuronidation by HLM and/or UGT2B7, due to an increase in K m /S 50 without a change in V max . Addition of BSA and HSA-FAF reversed the inhibition. Likewise, coexpression of UGT2B7 and HSA in HEK293 cells reduced the K m /S 50 values of these substrates. It is postulated that BSA and HSA-FAF sequester inhibitory fatty acids released during incubations, and the apparent high K m values observed for UGT2B7 substrates arise from the presence of these endogenous inhibitors.</abstract><cop>United States</cop><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>17237258</pmid><doi>10.1124/jpet.106.118216</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3565
ispartof The Journal of pharmacology and experimental therapeutics, 2007-04, Vol.321 (1), p.137-147
issn 0022-3565
1521-0103
language eng
recordid cdi_proquest_miscellaneous_70293028
source Freely Accessible Journals
subjects Albumins - pharmacology
Animals
Anti-HIV Agents - metabolism
Blotting, Western
Cattle
Chromatography, High Pressure Liquid
Data Interpretation, Statistical
Fatty Acids - metabolism
Glucuronides - metabolism
Glucuronosyltransferase - metabolism
Humans
Hymecromone - analogs & derivatives
Hymecromone - metabolism
In Vitro Techniques
Kinetics
Microsomes - metabolism
Protein Binding
Recombinant Proteins - metabolism
Serum Albumin - pharmacology
Serum Albumin, Bovine - pharmacology
Zidovudine - metabolism
title Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T02%3A51%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Binding%20of%20Inhibitory%20Fatty%20Acids%20Is%20Responsible%20for%20the%20Enhancement%20of%20UDP-Glucuronosyltransferase%202B7%20Activity%20by%20Albumin:%20Implications%20for%20in%20Vitro-in%20Vivo%20Extrapolation&rft.jtitle=The%20Journal%20of%20pharmacology%20and%20experimental%20therapeutics&rft.au=Rowland,%20Andrew&rft.date=2007-04-01&rft.volume=321&rft.issue=1&rft.spage=137&rft.epage=147&rft.pages=137-147&rft.issn=0022-3565&rft.eissn=1521-0103&rft_id=info:doi/10.1124/jpet.106.118216&rft_dat=%3Cproquest_cross%3E70293028%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-190b3446cb004d95134209b4f8de7f7ad288b4674d0d39403444c8cda2eec15d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70293028&rft_id=info:pmid/17237258&rfr_iscdi=true